Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Afessa, B., Greaves, W. L., & Frederick, W. R. (1995). Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin. Infect. Dis., 21, 345–351.
Almirall, J., Morato, I., Riera, F., Verdaguer, A., Priu, R., Coll. P., Vidal, J., Murgui, L., Valls, F., Catalant, F., & Balanzo, X. (1993). Incidence of community-acquired pneumonia and Chlamydia pneumoniae infections: a prospective multi-centre study. Eur. Resp. J. 6, 14–18.
Austrian, R. (1980). Surveillance of Pneumococcal Infection for Field Trials of Polyvalent Pneumococcal Vaccines. Publication DAB-VDP-12-84. Bethesda, Md: National Institute of Health.
Austrian, R., & Gold, J. (1964). Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med., 60, 759–776.
Austrian, R., Douglas, R. M., Schiffman, G., Coetzee, A. M., Koornhof, H. J., & Hayden-Smit, S. (1976). Prevention of pneumococcal infection by vaccination. Trans. Assoc. Am. Physicians, 89, 184–194.
Aszkenasy, O. M., George, R. C., & Begg, N. T. (1995). Pneumococcal bacteremia and meningitis in England and Wales in 1982 to 1992. Commun. Dis. Rep. CDR Rev., 31, 45–50.
Barker, W. H. (1986). Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970–78. Am. J. Pub. Health, 76, 761–765.
Bennett, N. M., Buffington, J., & LaForce, F. M. (1992). Pneumococcal bacteremia in Monroe County, New York. Am. J. Pub. Health, 82, 1513–1516.
Bentley, D. W. (1981). Pneumococcal vaccine in the institutionalized elderly: review of past and recent studies. Rev. Infect. Dis., 3(Suppl.):61–70.
Berntsson, E., Blomberg, J., Lagergard, T., & Trollfors, B. (1985). Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur. J. Clin. Microbiol. Infect. Dis., 4, 268–272.
Bolan, G., Broome, C. V., Facklam, R. R., Plikaytis, B. D., Fraser, D. W., & Schlech, W. F. III. (1986). Pneumococcal vaccine efficacy in selected populations in United States. Ann. Intern. Med., 104, 1–6.
Bouter, K. P., Diepersloot, R. J., van Romunde, L. K., Uitslager, R., Masurel, N., & Hoekstra, J. B. (1991). Effect of influenza epidemic on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976–1979 in The Netherlands. Diab. Res. Clin. Pract., 12, 61–68.
Brancati, F. L., Chow, J. W., Wagener, M. M., Vacarello, S. J., & Yu, V. L. (1993). Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia. Lancet, 342, 30–33.
Breiman, R. F., Spika, J. S., Navarro, V. J., Darden, P. M., & Darby, C. P. (1990). Pneumococcal bacteremia in Charleston County, South Carolina, a decade later. Arch. Intern. Med., 150, 1401–1405.
Burman, L. Å, Norrby, R., & Trollfors, B. (1985). Invasive pneumococcal infections: incidence, predisposing factors and prognosis. Rev. Infect. Dis., 7, 113–142.
Campbell, J. F., Donohue, M. A., Mochizuki, R. B., Nevin-Woods, C. L., & Spika, J. S. (1989). Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project. Hawaii Med. J., 48, 513–518.
Centers for Disease Control and Prevention (1995). Pneumonia and influenza death rates—United States, 1979–1994. MMWR, 44, 535–537.
Central Statistical Office of Finland (1985–1988, 1989). Statistical Year Book of Finland. Helsinki, Finland: State Printing Office.
Chakraverty, P., Cunningham, P., Shen, G. Z., & Pereira, M. S. (1986). Influenza in the United Kingdom 1982—1985. J. Hyg., 97, 347–358.
Cullinan, P. (1988). Respiratory disease in England and Wales. Thorax, 43, 949–954.
Davidson, M., Parkinson, A. J., Bulkow, L. R., Fitzgerald, M. A., Peters, H. V, & Parks, D. J. (1994). The epidemiology of invasive pneumococcal disease in Alaska, 1986–1990-ethnic differences and opportunities for prevention. J. Infect. Dis., 170, 368–376.
Diepersloot, R. J., Bouter, K. P., Hoekstra, J. B. (1990). Influenza infection and diabetes mellitus. Case for annual vaccination. Diab. Care, 13, 876–882.
Donowitz, G. R., & Mandell, G. L. (1995). Acute pneumonia, in: Principles and Practice of Infectious Disease, 4th ed. (G.L. Mandell, J.E. Bennett, & R. Dolin, eds.) New York: Churchill Livingstone, pp. 619–637.
Dorff, G. J., Rytel, M. W., Farmer, S. G., & Scanlon, G. (1973). Etiologies and characteristic features of pneumonias in a municipal hospital. Am. J. Med. Sci., 66, 349–358.
Dulake, C., & Selkon, J. (1982). The incidence of pneumonia in the UK—preliminary findings from Newcastle and London. Roy. Soc. Med. Symp. Series, 27, 87–94.
Farr, B. M., Bartlett, C. L. R., Wadsworth, J., & Miller, D. L. (1988). A case-control study of risk factors for community acquired pneumonia. 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, October, 23–26, Los Angeles. Abstract 1294.
Farr, B. M., Sloman, A. J., & Fisch, M. J. (1991). Predicting death in patients hospitalized for community-acquired pneumonia. Ann. Intern. Med., 115, 428–436.
Farr, B. M., Johnston, B. L., Cobb, D. K., Fisch, M. J., Germanson, T. P., Adal, K. A., Anglim, A. M. (1995). Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch. Intern. Med., 155, 2336–2440.
Fedson, D. S., & Baldwin, J. A. (1982). Previous hospital care as a risk factor for pneumonia. Implications for immunization with pneumococcal vaccine. JAMA, 246, 1989–1995.
Fedson, D. S., & Musher, D. M. (1994). Pneumococcal vaccine. In: Vaccines, 2d ed. (S. A. Plotkin & E. A. Mortimer, eds.). Philadelphia: W. B. Saunders Company, pp. 517–564.
Fedson, D., Henrichsen, J., & Mäkelä, P. H. (1989). Immunization of elderly people with polyvalent pneumococcal vaccine. Infection, 17, 437–441.
Fedson, D. S., Harward, M. P., Reid, R. A., & Kaiser, D. L. (1990). Hospital-based pneumococcal immunization. Epidemiologic rationale from the Shenandoah study. JAMA, 264, 1117–1122.
Fekety, F. R., Caldwell, J., Gump, D., Johnson, J. E., Maxson, W., Mulholland, J., & Thoburn, R. (1971). Bacteria, viruses and mycoplasmas in acute pneumonia in adults. Am. Rev. Respir. Dis., 104, 499–507.
Filice, G. A., Darby, C. P., & Fraser, D. W. (1980). Pneumococcal bacteremia in Charleston County, South Carolina. Am. J. Epidemiol., 112, 828–835.
Fine, M. J., Smith, D. N., & Singer, D. E. (1990). Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am. J. Med., 89, 713–721.
Fine, M. J., Singer, D. E., Hanusa, B. H., Lave, J. R., & Kapoor, W. N. (1993). Validation of a pneumonia prognostic index using the MedisGroups comparative hospital database. Am. J. Med., 94, 153–159.
Fine, M. J., Smith, M. A., Carson, C. A., Mutha, S., Sankey, S. S., Weissfeld, L. A., Kapoor, W. N. (1996). Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA, 275, 134–141.
Fine, M. L., Auble, T. E., Yealy, D. M., Hanusa, B. H, Weissfeld, L. A., Singer, D. E, Coley, C. M, Marrie, T. J., & Kapoor, W. N. (1997). A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med., 336, 243–250.
Finkelstein, M. S., Petkun, W. M, Freedman, M. L., & Antopol, S. C. (1983). Pneumococcal bacteremia in adults. J. Am. Geriatr. Soc., 31, 19–27.
Foy, H. M., Cooney, M. K., Allan, L., & Kenny, G. E. (1979). Rates of pneumonia during influenza epidemics in Seattle 1964 to 1975. JAMA, 241, 253–258.
Gable, C. B, Holzer, S. S, Engelhart, L., Friedman, R. B, Smeltz, F, Schroeder, D., & Baum, K. (1990). Pneumococcal vaccine. Efficacy and associated cost savings. JAMA, 264, 2910–2915.
Gaillat, J., Zmirou, D., Mallaret, M. R., Rouhan, D., Bru, J. P., Stahl, J. P, Delormas, P., & Micoud, D. (1985). Essai clinique du vaccin antipneumococcique chez des personnes âgées vivant en institution. Revue d’Epidemiologie et de Sante Publique, 33, 437–444.
Gilbert, K., & Fine, M. J. (1994). Assessing prognosis and predicting outcomes in community-acquired pneumonia. Semin. Respir. Inf., 9, 140–152.
Glezen, W. P, Decker, M., & Perotta, D. (1987). Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978–1981. Am. Rev. Respir. Dis., 136, 550–555.
Gransden, W. R, Eykyn, S. J., & Phillips, I. (1985). Pneumococcal bacteremia: 325 episodes diagnosed at St. Thomas’s Hospital. Br. Med. J., 290, 505–508.
Granton, J. T, & Grossman, R. F. (1993). Community-acquired pneumonia in the elderly patient. Clinical features, epidemiology, and treatment. Clin. Chest. Med., 14, 537–553.
Groop, L., Forsén, B., Niemelä, R., Pitkänen, M.-R., & Nordmyr, M. (1979). Tartuntatutien hoito terveyskeskuksessa (Management of infectious diseases in a municipal health center), (In Finnish). Suom Lääkäril, 34. 2772–2776.
Haglund, L. A, Istre, G. R, Pickett, D. A, Welch, D. F, Fine, D. P., and the Pneumococcus Study Group. (1993). Invasive pneumococcal disease in Central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J. Infect. Dis., 168, 1532–1536.
Hasley, P. B, Albaum, M. N, Li, Y. H, Fuhrman, C. R, Britton, C. A., Marrie, T. J, Singer, D. E, Coley, C. M, Kapoor, W. N., & Fine, M. J. (1996). Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch. Intern. Med., 156, 2206–2212.
Hedlund, J. U, Örtqvist, Å. B., Kalin, M, Scalia-Tomba, G., & Giesecke, J. (1992). Risk of pneumonia in patients previously treated in hospital for pneumonia. Lancet, 340, 396–397.
Hedlund, J. U, Örtqvist, A. B., Kalin, M. E., & Granath, F. (1993). Factors of importance for the long-term prognosis after hospital treated pneumonia. Thorax, 48, 785–789.
Hedlund, J., Svenson, S. B., Kalin, M., Henrichsen, J., Olsson-Liljequist, B., Möllerberg, G., & Källenius, G. (1995). Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin. Infect. Dis., 21, 948–953.
Hedlund, J, Kalin, M., & Örtqvist, A (1997). Recurrence of pneumonia in middle-aged and elderly adults after hospital-treated pneumonia: aetiology and predisposing conditions. Scand. J. Infect. Dis., 29, 387–392.
Holmberg, H. (1987). Aetiology of community-acquired pneumonia in hospital treated patients. Scand. J. Infect. Dis., 19, 491–501.
Honkanen, P. O, Keistinen, T., Miettinen, L., Herva, E., Sankilampi, U., Läärä, E., Leinonen, M., Kivelä, S.-L., Mäkelä, P. H. The incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine, 17, 2493–2500.
Istre, G. R., Tarpay, M., Anderson, M., Pryor, A., Welch, D., & the Pneumococcus Study Group. (1987). Invasive disease due to Streptococcus pneumoniae in an area with high rate of relative penicillin resistance. J. Infect. Dis., 156, 732–735.
Jokinen, C., Heiskanen, L., Juvonen, H., Kallinen, S., Karkola, K., Korppi, M., Kurki, S., Rönnberg, P.-R., Seppä, A., Soimakallio, L., Stén, M., Tanska, S., Tarkiainen, A., Tukiainen, H., Pyörälä, K., & Mäkelä, P. H. (1993). Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am. J. Epidemiol., 137, 977–988.
Jokinen, C., Heiskanen, L., Juvonen, H., Kallinen, S., Kleemola, M., Koskela, M., Leinonen, M., Rönnberg, P.-R., Saikku, P., Stén, M., Tarkiainen, A., Tukiainen, H., Pyörälä, K., & Mäkelä, P. H. (in press). Microbial etiology of community-acquired pneumonia in the adult population of four municipalities in Eastern Finland. Clin. Infect. Dis..
Kauppinen, M. T., Herva, E., Kujala, P., Leinonen, M., Saikku, P., Syrjälä, H. (1995). The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J. Infect. Dis., 172, 1330–1335.
Kerttula, Y, Leinonen, M., Koskela, M., & Mäkelä, P. H. (1987). The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J. Infect., 14, 21–30.
Koivula, I., Stén, M., & Mäkelä, P. H. (1994). Risk factors for pneumonia in the elderly. Am. J. Med., 96, 313–320.
Koivula, I., Stén, M., & Mäkelä, P. H. (1997). Clinical efficacy of the pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am. J. Med., 103, 282–290.
Koivula, L, Stén, M., & Mäkelä, P. H. (1999). Prognosis after community-acquired pneumonia in the elderly—a population-based 12-year follow-up study. Arch. Intern. Med., 159, 1550–1555.
Kramer, M. R., Rudensky, B., Hadas-Halperin, I., Isachson, M., & Melzer, E. (1987). Pneumococcal bacteremia—no change in mortality in 30 years: Analysis of 104 cases and review of the literature. Isr. J. Med. Sci., 23, 174–180.
Kuikka, A., Syrjänen, J., Renkonen, O-V., & Valtonen, V. (1992). Pneumococcal bacteremia during a recent decade. J. Infect., 24, 157–168.
Lääveri, T., Nikoskelainen, J., Meurman, O., Eerola, E., & Kotilainen, P. (1996). Bacteraemic pneumococcal disease in a teaching hospital in Finland. Scand, J. Infect. Dis., 28, 41–46.
LaCroix, A. Z., Lipson, S., Miles, T., & White, L. (1989). Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors and nutritional status. Pub. Health Rep., 104, 350–369.
Lange, P., Vestbo, J., Nyboe, J. (1995). Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur. Respir. J., 8, 1694–1698.
Leech, J. A., Gervais, A., & Ruben, F. L. (1987). Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. Can. Med. Assoc. J., 136, 361–365.
Levy, M., Dromer, F., Brion, N., Leturdu, F., & Carbon, C. (1988). Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest., 92, 43–48.
Lieberman, D., Schlaeffer, F., Boldur, I., Lieberman, D., Horowitz, M. G., Leinonen, M., Horowitz, O., Manor, E., & Porath, A. (1996). Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax, 51, 179–184.
Lieberman, D., Lieberman, D., Schlaeffer, F., & Porath, A. (1997). Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home. Age Ageing, 26, 69–75.
Lipsky, B. A., Boyko, E. J., Inui, T. S., Koepsell, T. D. (1986). Risk factors for acquiring pneumococcal infections. Arch. Intern. Med., 146, 2179–2185.
Macfarlane, J. (1987). Community-acquired pneumonia. Br. J. Dis. Chest, 81, 116–127.
Macfarlane, J. (1994). An overview of community-acquired pneumonia with lessons learned from the British Thoracic Society Study. Semin. Respir. Infect., 9, 153–165.
Macfarlane, J. T., Finch, R. G., Ward, M. J., & Macrae, A. D. (1982). Hospital study of adult community-acquired pneumonia. Lancet, 2, 255–258.
Macfarlane, J. T., Colville, A., Guion, A., Macfarlane, R. M., & Rose, D. H. (1993). Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet, 34, 511–514.
Mäkelä, P. H., Jokinen, C., Koivula, I., Mäkelä, M., & Pyhälä, R. (1993). Pneumonia in the elderly and cost-effectiveness of influenza vaccination, in: Options for the Control of Influenza II (A. P. Hannoun, H. D. Klenk, & F. L. Ruben, eds.). New York: Elsevier Science Publishers, pp. 63–68.
Marrie, T. J. (1990). Epidemiology of community-acquired pneumonia in the elderly. Semin. Respir. Infect., 5, 260–268.
Marrie, T. J., Durant, H., & Kwan, C. (1989). Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev. Infect. Dis., 11, 586–599.
Marston, B. J., Plouffe, J. F, File, T. M., Hackman, B. A., Salström, S., Lipman, H. B., Kolczak, M. S., & Breiman, R. F. (1997). Incidence of community-acquired pneumonia requiring hospitalization. Arch. Intern. Med., 157, 1709–1718.
McConnochie, K. M., Hall, C. B., & Barker, W. H. (1988). Lower respiratory tract illness in the first two years of life: epidemiologic patterns and costs in a suburban pediatric practice. Am. J. Pub. Health, 78, 34–39.
Metlay, J. P., Schulz, R., Li, Y. H., Singer, D. E., Marrie, T. J., Coley, C. M., Hough, L. J., Obrosky, D. S., Kapoor, W. N., & Fine, M. J. (1997). Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch. Intern. Med., 157, 1453–1459.
Moss, J. M. (1980). Pneumococcal infection in diabetes mellitus. Is this a justification for immunization? JAMA, 22, 2301–2303.
Mufson, M. A., Oley, G., & Hughey, D. (1982). Pneumococcal disease in a medium-sized community in the United States. JAMA, 248, 1486–1489.
Murphy, T. F, & Fine, B. C. (1984). Bacteremie pneumococcal pneumonia in the elderly. Am. J. Med. Sci., 288, 114–118.
Murphy, T. F, Henderson, F. W., Clyde, W. A. Jr., Collier, A. M., & Denny, F. W. (1981). Pneumonia: an eleven-year study in a pediatric practice. Am. J. Epidemiol., 113, 12–21.
Nichol, K. L., Margolis, K. L., Wuorenma, J., Von Sternberg, T. (1994). The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med., 331, 778–784.
Nielsen, S. V, & Henrichsen, J. (1992). Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982–1987. Clin. Infect. Dis., 15, 794–798.
Örtqvist, Å., Grepe, A., Julander, I., & Kalin, M. (1988). Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand. J. Infect. Dis., 20, 163–171.
Örtqvist, Å., Hedlund, J., Grillner, L., Jalonen, E., Kallings, I., Leinonen, M., & Kalin, M. (1990). Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur. Respir. J., 3, 1105–1113.
Örtqvist, Å., Hedlund, J., Burman, L.-Å., Höfer, M., Leinonen, M., Lindblad, L, Sundelöf, B., Kalin, M., & Swedish Pneumococcal Vaccination Study Group. (1998). Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet, 351, 399–403.
Oseasohn, R., Skipper, B. E., & Tempest, B. (1978). Pneumonia in a Navajo Community. Am. Rev. Respir. Dis., 117, 1003–1009.
Pastor, P., Medley, F., & Murphy, T. V. (1998). Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin. Infect. Dis., 26, 5.
Patrick, K. M., & Woolley, F. R. (1981). A cost-benefit analysis of immunization for pneumococcal pneumonia. JAMA, 245, 473–477.
Plouffe, J. F., Breiman, R. F., Facklam, R. R., & the Franklin County Pneumonia Study Group. (1996). Bacteremia with Streptococcus pneumoniae in adults. Implications for therapy and prevention. JAMA, 275, 194–198.
Rello, J., Rodriguez, R., Jubert, P., Alvarez, B., & the Study Group for Severe Community-Acquired Pneumonia. (1996). Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Clin. Infect. Dis., 23, 723–728.
Research Committee of the British Thoracic Society and the Public Health Laboratory Service (1987). Community-acquired pneumonia in adults in British hospitals in 1982–1983: A survey of aetiologic, mortality, prognostic factors and outcome. Q. J. Med., 62, 195–220.
Riley, I. D., Tarr, P. I., & Andrews, M. (1977). Immunization with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet, 1, 1338–1341.
Ruben, F. L., Norden, C. W., & Korica, Y. (1984). Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980. Am. J. Med., 77, 1091–1094.
Salive, M. E., Satterfield, S., Ostfeld, A. M., Wallace, R. B., & Havlik, R. J. (1993). Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults. Pub. Health Rep., 108, 314–322.
Sankilampi, U. (1997). Streptococcus pneumoniae and the elderly: an epidemiological and serological study focusing on the potential of the polysaccharide vaccine. Doctoral dissertation, Universitatis Ouluensis.
Sankilampi, U., Herva, E., Haikala, R., Liimatainen, O., Renkoncn, O.-V., & Leinonen, M. (1997). Epidemiology of invasive infections in adults in Finland. Epidemiol. Infect., 118, 7–15.
Säynäjäkangas, P., Keistinen, T., Honkanen, P. O., & Kivelä, S.-L. (1997). Hospital discharges for pneumonia in Finland between 1972–1993 in the population aged 65 years or over. Age Ageing, 26, 269–273.
Shapiro, E. D., & Clemens, J. D. (1984). A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann. Intern. Med., 101, 325–330.
Shapiro, E. D., Berg, A. T, Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991). The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med., 325, 1453–1460.
Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geisler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., & Shephard, D. S. (1986). Efficacy of pneumococcal vaccine in high-risk patients. N. Engl. J. Med., 315, 1318–1327.
Sims, R. V., Steinmann, W. C., McConville, J. H., King, L., Zwick, W. C., & Schwart, J. S. (1988). The clinical effectiveness of pneumococcal vaccine in the elderly. Ann. Intern. Med., 108, 653–657.
Smit, P., Oberholzer, D., Hayden-Smith, S., Koornhof, H. J., & Hilleman, M. R. (1977). Protective efficacy of pneumococcal polysaccharide vaccines. JAMA, 238, 2613–2616.
Smith, M. D., Stuart, J., Andrews, N. J., Telfer Brunton, W. A., & Cartwright, K. A. V. (1998). Invasive pneumococcal infection in south and west England. Epidemiol. Infect., 120, 117–123.
Trotman, J., Hughes, B., & Mollison. L. (1995). Invasive pneumococcal disease in central Australia. Clin. Infect. Dis., 20, 1553–1556.
Venkatesan, P., Gladman, J., Macfarlane, J. T., Barer, D., Berman, P., Kinnear, W., & Finch, R. G. (1990). A hospital study of community-acquired pneumonia in the elderly. Thorax, 45, 254–258.
Virtanen, M., & Peltola, H. Bacteremia and purulent meningitis in Finland, 1982. An analysis of positive blood cultures and cerebrospinal fluid cultures in 1976–1980 (in Finnish). Duodecim., 98, 1315–1325.
Woodhead, M. A., Macfarlane, J. T., Rodgers, F. G., Laverick, A., Pilkington, R., & Macrae, A. D. (1987). Prospective study of aetiology and outcome of pneumonia in the community. Lancet, 1, 671–674.
Zangwill, K. M., Vadheim, C. M., Vannier, A. M., Hemenway, L. S., Greenberg, D. P., & Ward, J. I. (1996). Epidemiology of invasive pneumococcal disease in Southern California: implications for design and conduct of a pneumococcal conjugate vaccine trial. J. Infect. Dis., 174, 752–759.
Zweig, S., Lawhorne, L., & Post, R. (1990). Factors predicting mortality in rural elderly hospitalized for pneumonia. J. Fam. Pract., 30, 153–159.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Koivula, I.H. (2002). Epidemiology of Community-Acquired Pneumonia. In: Marrie, T.J. (eds) Community-Acquired Pneumonia. Springer, Boston, MA. https://doi.org/10.1007/0-306-46834-4_2
Download citation
DOI: https://doi.org/10.1007/0-306-46834-4_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46432-4
Online ISBN: 978-0-306-46834-6
eBook Packages: Springer Book Archive